Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.38 |
| ▸ | CHKA | P35790 | 5/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CHKB | Q9Y259 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | PDE5A | O76074 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24774796 | 0.93 | CHKA (0.40) | TNKS2CHKAHSD17B1HSD17B2TAAR1 | |
| SCHEMBL24794314 | 0.87 | TAAR1 (0.41) | TNKS2HSD17B1HSD17B2TAAR1MAOA | |
| SCHEMBL6724189 | 0.83 | CHKA (0.49) | CHKAHSD17B1HSD17B2TAAR1ABCG2 | |
| SCHEMBL24774787 | 0.83 | DHODH (0.30) | DHODH | |
| SCHEMBL6723961 | 0.81 | CHKA (0.51) | CHKAHSD17B1HSD17B2TAAR1ABCG2 | |
| SCHEMBL6723762 | 0.81 | CHKA (0.50) | CHKAHSD17B1HSD17B2DHODHTAAR1 | |
| SCHEMBL6723784 | 0.80 | CHKA (0.50) | CHKAHSD17B1HSD17B2TAAR1MAOA | |
| SCHEMBL6723434 | 0.80 | CHKA (0.50) | CHKAHSD17B1HSD17B2TAAR1MAOA | |
| SCHEMBL6724011 | 0.80 | CHKA (0.50) | CHKAHSD17B1HSD17B2TAAR1MAOA | |
| SCHEMBL13826088 | 0.80 | CHKA (0.50) | CHKAHSD17B1HSD17B2TAAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230345832-A1 | FLUORESCENT MATERIAL AND ELECTROLUMINESCENT DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2023-10-26 | — | — | US | disclosed |
| US-20230345832-A1 | FLUORESCENT MATERIAL AND ELECTROLUMINESCENT DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2023-10-26 | — | — | US | disclosed |
| WO-2022262063-A1 | FLUORESCENT MATERIAL AND ELECTROLUMINESCENT DEVICE | 武汉华星光电技术有限公司 | 2022-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230345832-A1 | FLUORESCENT MATERIAL AND ELECTROLUMINESCENT DEVICE | ICMT, GFPT1, TTN | TNKS2 1817/4885CHKA 3229/4885HSD17B1 4804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.